14.11.2012 Views

Program Book

Program Book

Program Book

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

have highlighted a role for specific cell signaling pathways and the<br />

tumor microenvironment in the biology of this tumor. In this study we<br />

performed immunohistochemical studies in a relatively large series of<br />

OPG using tissue microarrays.<br />

Methods. Tumors from 59 patients with a median age of 9 years (range<br />

3 mo-66 years; 33 F,26 M) were tested using formalin-fixed paraffin<br />

embedded material in tissue microarrays. Immunohistochemistry<br />

was performed using antibodies recognizing mTOR pathway signaling<br />

components (total mTOR protein, Phospho-4E-BP1, PhosphoeIf4G,<br />

phosho-S6), microglia (CD68), markers of senescence (p16),<br />

and mutant IDH1 protein. Scoring was performed using a 4-tiered<br />

semiquantitative scale (0-4+). IDH1 was scored as positive or negative.<br />

Immunohistochemistry for GFAP was performed to evaluate for adequacy<br />

of immunoreactivity.<br />

Results. Immunohistochemical stains demonstrated frequent staining<br />

for mTOR pathway components, including moderate (2+) to strong (3+)<br />

staining for total mTOR (50%), phospho-4E-BP1 (42%), phospho-eIf4G<br />

(75%), and phospho-S6 (70%). Moderate to marked numbers of CD68<br />

positive microglia were identified in 44% of cases. Moderate to diffuse<br />

nuclear immunoreactivity for p16 was identified in 59% of cases. All<br />

cases (except for 1) were immunonegative for IDH1 mutant protein.<br />

Conclusions. OPG demonstrate increased total/activated levels of mTOR<br />

signaling components supporting an important role for this pathway<br />

in its biology. In addition, increased numbers of CD68+ microglia and<br />

markers of senescence (p16) were identified. These findings merit<br />

further study and correlation with additional molecular markers to<br />

evaluate their clinical and biological significance.<br />

Financial disclosure. None<br />

EYELID, CONJUNTIVA & ORBIT<br />

Abstract Posters<br />

86<br />

Other Intra-ocular Tumors Posters<br />

131 OTp101<br />

PHOTODYNAMIC THERAPY FOR ACQUIRED ASTRO-<br />

CYTOMA<br />

Cinzia Mazzini, Maria Carla Donati, Giulia Pieretti, Ugo Menchini (cinzia.<br />

mazzini@unifi.it)<br />

Department of Specialistic Surgery Sciences, Eye Clinic, University of<br />

Florence, Florence, Italy.<br />

Purpose. Retinal astrocytomas are glial tumours of the RNFL arising from<br />

retinal astrocytes, often associated with systemic disorders ( tuberous<br />

sclerosis or neurofibromatosis) but they can also be found on retinal<br />

examination as isolated tumour. We report the case of epipapillary<br />

retinal astrocytoma associated with serous retinal detachment treated<br />

with photodynamic therapy (PDT).<br />

Methods. A 32-years old man was referred for an elevated whitish<br />

epipapillary lesion associated with retinal detachment. He had a history<br />

of multicellular carcinoma and melanocytic nevus of the scapular region.<br />

Visual acuity was 20/20 in both eyes. Fluorescein angiography revealed<br />

a hyperfluorescence of the lesion; B-scan showed a solid epipapillary<br />

tumour with high reflectivity, posterior shadowing, and a contiguous<br />

serous retinal detachment. OCT showed a solid elevation of the retinal<br />

layers associated with raised neuro-epithelium at the edge of the lesion.<br />

The clinical picture was consistent with “acquired astrocytoma”.<br />

Four years later, the patient complained of a severe visual loss in left<br />

eye. BCVA was 20/50 and fundus examination, echography, fluorescein<br />

angiography and OCT showed an enlargement of the lesion and retinal<br />

detachment, with macular exudation. PDT with verteporfirin was performed.<br />

Results. Three months after treatment visual acuity remained stable;OCT<br />

and echography revealed a decrease of subretinal fluid. One year later<br />

BCVA was 20/30, and retinal detachment was disappeared.<br />

Conclusions. PDT with verteporfin can induce regression of aggressive<br />

retinal astrocytomas and may prevent their progression to total retinal<br />

detachment and enucleation. In selected severe cases, PDT may be<br />

considered a first-line treatment for acquired astrocytomas.<br />

Financial disclosure. None<br />

530 OTp102<br />

MANAGEMENT OF PERIPAPILLARY HEMANGIOMA IN<br />

PEDIATRIC VHL DISEASE<br />

Prithvi Mruthyunjaya, MD (mruth001@mc.duke.edu)<br />

Ocular Oncology and Vitreoretinal Surgery Services, Duke Eye Center,<br />

Durham, NC<br />

Purpose. To describe the management of a peripapillary retinal<br />

hemangioma in a pediatric patient with von-Hippel-Lindau disease and<br />

to describe the early development of epiretinal proliferations in this<br />

disease.<br />

Methods. Case report of a 2 yo male with a strong family history of VHL<br />

disease who presents with a new peripapillary hemangioma associated<br />

with a dome-shaped epimacular elevation.<br />

Results. Intraoperative photodynamic therapy was performed with<br />

verteporfin and intravitreal Avastin on 2 occasions with subsequent<br />

inactivation of the peripapillary hemangioma. The macular elevation<br />

was likely due to vitreous traction on the macular hyloid bursa with

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!